Arie Mayer
Director/Board Member at ORAMED PHARMACEUTICALS INC.
Net worth: 221 108 $ as of 29/04/2024
Profile
Arie Mayer is currently the Chairman & Managing Director at Sigma-Aldrich Israel Ltd.
since 2010 and an Independent Director at Oramed Pharmaceuticals, Inc. since 2019.
He holds a doctorate degree from Technion-Israel Institute of Technology and an undergraduate degree from The Hebrew University of Jerusalem.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 05/03/2024 | 96,134 ( 0.24% ) | 221 108 $ | 29/04/2024 |
Arie Mayer active positions
| Companies | Position | Start |
|---|---|---|
| ORAMED PHARMACEUTICALS INC. | Director/Board Member | 04/12/2019 |
Sigma-Aldrich Israel Ltd.
 Sigma-Aldrich Israel Ltd. Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, Sigma-Aldrich Israel Ltd. is an Israeli pharmaceutical company that manufactures pharmaceutical products. The private company is based in Rehovot, Israel. Arie Mayer has been the CEO of the company since 1995. | Chief Executive Officer | 31/12/2009 |
Training of Arie Mayer
| Technion-Israel Institute of Technology | Doctorate Degree |
| The Hebrew University of Jerusalem | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ORAMED PHARMACEUTICALS INC. | Health Technology |
| Private companies | 1 |
|---|---|
Sigma-Aldrich Israel Ltd.
Sigma-Aldrich Israel Ltd. Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, Sigma-Aldrich Israel Ltd. is an Israeli pharmaceutical company that manufactures pharmaceutical products. The private company is based in Rehovot, Israel. Arie Mayer has been the CEO of the company since 1995. | Health Technology |
- Stock Market
- Insiders
- Arie Mayer
